Contacts

MedinCell announces the initiation of coverage of its stock by TPICAP Midcap

January 5, 2023

TPICAP Midcap initiated coverage of MedinCell’s stock with a study entitled “Pipeline maturation: 1st launch likely in H1-23“, giving a recommendation to buy the stock with a price target of 15 euros per share.

Session en français

Rendez-vous le mardi 2 mai à 18h30 pour une vidéoconférence dédiée à l'approbation de UZEDY™

English session

On Tuesday, May 2 at 7.30 pm (CEST) participate in our videoconference dedicated to the approval of UZEDY™

Êtes-vous un actionnaire de MedinCell ? / Are you a MedinCell shareholder?
Vous êtes / You are :
This field is for validation purposes and should be left unchanged.

CONTACT

  • This field is for validation purposes and should be left unchanged.